Benralizumab (Fasenra)

From HemOnc.org - A Hematology Oncology Wiki

Revision as of 10:07, 4 April 2021 by Cafitts (talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

General information

Class/mechanism: A humanized monoclonal antibody targeting interleukin-5 (IL-5).

Diseases for which it is used

Hypereosinophilic syndrome (HES)

History of changes in FDA indication

No approval for hematology/oncology conditions, at this time.

Patient Drug Information

Benralizumab (Fasenra) Package Insert^[1]

Also known as

Brand names: Fasenra

References

↑ Benralizumab (Fasenra) Package Insert

Retrieved from "https://hemonc.org/w/index.php?title=Benralizumab_(Fasenra)&oldid=48245"